Literature DB >> 24189317

Outcomes after prolonged extracorporeal membrane oxygenation support in children with cardiac disease--Extracorporeal Life Support Organization registry study.

Eric Dean Merrill1, Laura Schoeneberg1, Pratik Sandesara1, Erica Molitor-Kirsch2, James O'Brien2, Hongying Dai2, Geetha Raghuveer3.   

Abstract

OBJECTIVE: Extracorporeal membrane oxygenation remains the mainstay of mechanical circulatory support initiation and maintenance in children with cardiac insufficiency. However, the outcomes after prolonged extracorporeal membrane oxygenation for cardiac insufficiency in children remain ill defined.
METHODS: We reviewed the International Extracorporeal Life Support Organization data from January 1, 2000, through December 31, 2011. We defined prolonged extracorporeal membrane oxygenation as uninterrupted support for ≥14 days.
RESULTS: A total of 777 children aged <18 years required extracorporeal membrane oxygenation support for ≥14 days. Of these, 176 (23%) survived to hospital discharge. Compared with the nonsurvivors, the survivors were older (median age, 0.64 vs 0.10 years; P < .01), weighed more (median weight, 7.0 kg; range, 2-90; vs median, 4.0; range, 1.4-100 kg; P < .01), had a shorter duration of support (mean, 20 ± 6 vs 22 ± 9 days; P < .01), and a fewer number of organ system complications (mean, 2.8 ± 1.7 vs 3.6 ± 1.6, P < .01). Children with congenital heart disease had worse survival than those with cardiomyopathy and myocarditis (15% vs 42% and 52%, respectively; P < .01), and those with 1-ventricle physiology had worse survival than those with 2-ventricle physiology (10% vs 18%, P = .01). Seven percent (n = 56) reached cardiac transplantation, with 66% surviving to hospital discharge versus 19% of those not transplanted (P < .01).
CONCLUSIONS: The attrition is high after prolonged extracorporeal membrane oxygenation support for cardiac insufficiency in children. Cardiac transplantation in this cohort was rarely achieved and was associated with high mortality compared with benchmarks for cardiac transplantation survival. Earlier redirection of care or conversion to other modes of mechanical support as a bridge to transplantation should be considered.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24189317     DOI: 10.1016/j.jtcvs.2013.09.038

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

1.  Right ventricular metabolism during venoarterial extracorporeal membrane oxygenation in immature swine heart in vivo.

Authors:  Masaki Kajimoto; Dolena R Ledee; Nancy G Isern; Michael A Portman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-02-03       Impact factor: 4.733

2.  Neonatal respiratory extracorporeal membrane oxygenation and primary diagnosis: trends between two decades.

Authors:  Jotishna Sharma; Ashley Sherman; Anisha Rimal; Barb Haney; Julie Weiner; Eugenia Pallotto
Journal:  J Perinatol       Date:  2019-11-07       Impact factor: 2.521

3.  Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders.

Authors:  J Vockley; J Charrow; J Ganesh; M Eswara; G A Diaz; E McCracken; R Conway; G M Enns; J Starr; R Wang; J E Abdenur; J Sanchez-de-Toledo; D L Marsden
Journal:  Mol Genet Metab       Date:  2016-08-27       Impact factor: 4.797

Review 4.  An Alternative Strategy for Bridge-to-Transplant/Recovery in Small Children with Dilated Cardiomyopathy.

Authors:  Gilles Mets; Joseph Panzer; Daniël De Wolf; Thierry Bové
Journal:  Pediatr Cardiol       Date:  2017-03-29       Impact factor: 1.655

5.  Outcomes of Extracorporeal Membrane Oxygenation in Patients After Repair of Congenital Heart Defects.

Authors:  Serdar Basgoze; Bahar Temur; Selim Aydın; Fusun Guzelmeric; Osman Guvenc; Ayhan Cevik; Muzeyyen Iyigun; Ersin Erek
Journal:  Pediatr Cardiol       Date:  2022-05-09       Impact factor: 1.838

6.  Outcomes and associated ethical considerations of long-run pediatric ECMO at a single center institution.

Authors:  Guillermo J Ares; Christie Buonpane; Irene Helenowski; Marleta Reynolds; Catherine J Hunter
Journal:  Pediatr Surg Int       Date:  2019-01-25       Impact factor: 1.827

7.  Differential effects of octanoate and heptanoate on myocardial metabolism during extracorporeal membrane oxygenation in an infant swine model.

Authors:  Masaki Kajimoto; Dolena R Ledee; Aaron K Olson; Nancy G Isern; Christine Des Rosiers; Michael A Portman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-31       Impact factor: 4.733

8.  Cardiac failure in very long chain acyl-CoA dehydrogenase deficiency requiring extracorporeal membrane oxygenation (ECMO) treatment: A case report and review of the literature.

Authors:  Sharon Katz; Yuval Landau; Ben Pode-Shakked; Itai M Pessach; Marina Rubinshtein; Yair Anikster; Yishay Salem; Gideon Paret
Journal:  Mol Genet Metab Rep       Date:  2016-12-08

9.  Outcomes of Extracorporeal Membrane Oxygenation in Children: An 11-Year Single-Center Experience in Korea.

Authors:  Hongsun Kim; Ji-Hyuk Yang; Yang Hyun Cho; Tae-Gook Jun; Kiick Sung; Woosik Han
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2017-10-05

10.  Cardiac Catheterization During Extracorporeal Membrane Oxygenation After Congenital Cardiac Surgery: A Multi-Center Retrospective Study.

Authors:  Gaser Abdelmohsen; Jameel Al-Ata; Naif Alkhushi; Saud Bahaidarah; Haysam Baho; Mohamed Abdelsalam; Samia Bekheet; Wejdan Ba-Atiyah; Abdulhadi Alghamdi; Ahmed Fawzy; Ahmed Elakaby; Osman Al-Radi; Ahmed Jamjoom; Ahmed Elassal; Mohammad Shihata; Ahmed Azhar; Zaher Zaher; Khadijah Maghrabi; Mohamed Mashali; Ahmed Dohain
Journal:  Pediatr Cardiol       Date:  2021-07-30       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.